Information on the regulation of medicines for human use in the european union (eu), with a focus on the centralised procedure The european medicines agency (ema) publishes detailed information on the medicines assessed by the committee for medicinal products for human use (chmp) and committee for medicinal products for veterinary use (cvmp). The european medicines agency (ema) plays a key role in this procedure.
Ema Santi - a model from Germany | Model Management
Ema concludes its two mandates as chair icmra elects new chair in amsterdam
The european medicines agency (ema) is responsible for the scientific evaluation of centralised marketing authorisation applications (maa)
Once granted by the european commission, the centralised marketing authorisation is valid in all european union (eu) member states, iceland, norway and liechtenstein. On this page you can find several ways to contact the european medicines agency (ema) depending on your need for assistance or type of request. Check ema's annual reports for insights into our regulatory procedures, activities, and achievements The reports include an interactive timeline and figures and statistics for easy comprehension.
The european medicines agency's committee for medicinal products for human use prepares scientific guidelines in consultation with regulatory authorities in the european union (eu) member states, to help applicants prepare marketing authorisation applications for human medicines Guidelines reflect a harmonised approach of the eu member states and the agency on how to interpret and apply the.
